Cancer Advances is Drug Discovery in United States that focus on Polyclonal Antibody Stimulator business. Founded in 2008. They cover business area such as developer, oncology drug, life, patient, gastrointestinal cancer, PAS, an immunomodulator, gastrin, tumor growth, metastasis, physician, medical outcome.
2008
( 16 years old in 2024 )
Polyclonal Antibody Stimulator
-
Westpark Corporate Center
4364 South Alston Avenue, Suite 105
Durham, NC 27713
United States
Private
developeroncology druglifepatientgastrointestinal cancerPASan immunomodulatorgastrintumor growthmetastasisphysicianmedical outcome
* We use standard office opening hours in near Cancer Advances's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cancer Advances is Drug Discovery business from United States that founded in 2008 (16 years old in 2024), Cancer Advances business is focusing on Polyclonal Antibody Stimulator.
Cancer Advances headquarter office and corporate office address is located in Westpark Corporate Center 4364 South Alston Avenue, Suite 105 Durham, NC 27713 United States.
Cancer Advances was founded in United States.
In 2024, Cancer Advances is currently focus on Polyclonal Antibody Stimulator sector.
Above is snippet of Google Trends for "Polyclonal Antibody Stimulator" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cancer Advances, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
